Trials / Completed
CompletedNCT02942524
Checklist Tool in Engaging Patients in the Discharge Planning Process
Tool to Engage Patients in Discharge (TEPID)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 450 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial studies how well a checklist tool works in engaging patients in the discharge planning process. Engaging patients in the discharge process may increase participation in the discharge process and improve discharge outcomes, understanding of care after hospitalization, and decrease complications.
Detailed description
PRIMARY OBJECTIVES: I. Measure the impact on discharge and transition satisfaction of utilizing questions from the Consumer Assessment of Healthcare Providers and Systems (CHAPS) patient satisfaction survey. II. Measure the impact of the Tool to Engage Patients in Discharge (TEPID) on patient's Readiness for Hospital Discharge and Problems After Discharge Questionnaire-English (PADQ-E) results. III. Measure the impact on decreasing healthcare utilization measures: readmission rates within 30 days from hospital discharge, hospital length of stay of admission in hospital, and emergency department visits within 30 days of hospital discharge. OUTLINE: Patients complete the TEPID checklist of items during hospital stay. After completion of the study, patients are followed up for 35 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Communication Intervention | Complete TEPID |
| OTHER | Questionnaire Administration | Ancillary studies |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-08-04
- Completion
- 2017-08-04
- First posted
- 2016-10-24
- Last updated
- 2020-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02942524. Inclusion in this directory is not an endorsement.